Russell Wilson

Nessuna posizione attualmente

64 anni

Health Technology

Consumer Services

Profilo

Attualmente, Russell P. Wilson ricopre la posizione di vicepresidente senior dello sviluppo aziendale di Novavax, Inc. In precedenza ha occupato la posizione di direttore finanziario e vicepresidente presso Supernus Pharmaceuticals, Inc., direttore finanziario, segretario e vicepresidente senior presso Intercell USA, Inc. e consigliere generale presso North American Vaccine, Inc. Ha conseguito un MBA e una laurea presso l'Università della Virginia e una laurea presso la Princeton University.

Precedenti posizioni note di Russell Wilson

Società	Posizione	Fine
NOVAVAX, INC.	Chief Tech/Sci/R&D Officer	28/03/2012
IOMAI CORPORATION	Director of Finance/CFO	01/08/2008
North American Vaccine, Inc. North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million.	General Counsel	01/01/2000
SUPERNUS PHARMACEUTICALS, INC.	Director of Finance/CFO	-

Vedi nel dettaglio l'esperienza di Russell Wilson

Formazione di Russell Wilson

University of Virginia	Graduate Degree
Princeton University	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Russell Wilson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
NOVAVAX, INC.	Health Technology
SUPERNUS PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
North American Vaccine, Inc. North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million.	Health Technology
Intercell USA, Inc. Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD.	Health Technology